COVID-19 vaccine support items coming to an end From 1 July, the MBS items for vaccine suitability assessments, and associated items, introduced during the pandemic, will cease.
TGA warns of ‘possible but rare’ RSV vaccines risk Product Information for Arexvy and Abrysvo has been updated to reflect a low risk of Guillain-Barre Syndrome following vaccination.
Fresh push to turn around ‘dire’ flu vaccination rate The RACGP has joined calls to boost influenza vaccinations as cases continue to climb, with increases seen across all Australian jurisdictions.
GPs remain the frontline in vaccination With the WHO warning global immunisation gains are at risk, an RACGP expert says GPs are best placed to get vaccination rates up.
Study examines whether RSV vaccine lasts ‘at least three winters’ The results of a randomised controlled trial indicate an RSV vaccine could offer protection against the virus over three seasons in over 60s.
In Practice: EOIs for education research grants The Education Research Grant program supports research to strengthen the future of medical education and general practice training.
RACGP calls for action as flu cases reach record high With cases skyrocketing to almost 50,000 in 2025, the college is calling on GPs and the community to ‘work together and get vaccinated’.
Study suggests answer to reducing RSV hospital admissions Research evaluating the effectiveness of RSV vaccination among babies in WA has found a significant reduction in hospital admissions.
What is stopping kids getting a flu vaccination? A survey of Australian parents has revealed the practical difficulties and acceptance barriers leading to falling vaccination rates.
In Practice: 2025 flu vaccines arriving early April Delivery of Sanofi’s VaxiGrip Tetra vaccine for this year’s influenza season is expected to arrive within weeks, the DoHAC confirmed.